Literature DB >> 16343104

Apoptosis is reduced in the colonic mucosa of patients with acromegaly.

Fausto Bogazzi1, Dania Russo, Maria Teresa Locci, Barbara Chifenti, Federica Ultimieri, Francesco Raggi, Chiara Cosci, Chiara Sardella, Aurelio Costa, Maurizio Gasperi, Luigi Bartalena, Enio Martino.   

Abstract

BACKGROUND: Patients with acromegaly have an increased risk of developing colonic tumours; reduced apoptosis is considered a leading mechanism in tumorigenesis. GH and IGF-1 decrease apoptosis in several cell lines including human colonic adenocarcinoma, but it is unknown whether epithelial cells of colonic mucosa of patients with acromegaly have reduced apoptosis. AIM: The aim of the study was to evaluate the degree of apoptosis in a cross-sectional study, in biopsy samples of colonic mucosa obtained from patients with acromegaly. PATIENTS AND METHODS: Eleven patients with active, untreated acromegaly (AcroUntr), 16 patients with acromegaly in remission (AcroRem) and 23 controls were enrolled in the study. Samples of colonic mucosa were obtained during colonoscopy; apoptosis was evaluated by either DNA fragmentation or terminal deoxynucleotidyl transferase assay.
RESULTS: Apoptotic cells were 60.0 +/- 2.5% in samples of colonic mucosa of controls, 62.0 +/- 3.4% in those from patients with AcroRem (P = ns vs. controls), and 39.0 +/- 4.1% in those from patients with AcroUntr (P < 0.0001 vs. the other groups). Apoptosis was inversely related to serum IGF-I (r = 0.771, P < 0.001) or GH (r = 0.404, P = 0.05) levels and less to the estimated duration of disease (r = 0.384, P = 0.07). PPARgamma is considered to be a tumour suppressor gene the expression of which might be involved in colonic tumorigenesis. The expression of PPARgamma was lower in the colonic mucosa of patients with AcroUntr (2845 +/- 947 transcripts) than in that of controls (35 200 +/- 2450 transcripts) or AcroRem (29 547 +/- 3650 transcripts) (P < 0.005). The recovery of PPARgamma expression was associated with apoptosis in most cells. The lower degree of apoptosis in patients with AcroUntr was associated with a reduced expression of the antiapoptotic Bax protein.
CONCLUSION: In conclusion, patients with AcroUntr have reduced apoptosis in colonic mucosa that is apparently reversed after acromegaly is cured. It is conceivable that reduced apoptosis may represent an early event in colonic tumorigenesis of patients with acromegaly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16343104     DOI: 10.1111/j.1365-2265.2005.02405.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Increased thyroid cancer risk in acromegaly.

Authors:  Selcuk Dagdelen; Nese Cinar; Tomris Erbas
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

2.  Comparison of colonoscopy and fecal occult blood testing as a first-line screening of colonic lesions in patients with newly diagnosed acromegaly.

Authors:  F Bogazzi; M Lombardi; I Scattina; C Urbani; E Marciano; A Costa; P Pepe; G Rossi; E Martino
Journal:  J Endocrinol Invest       Date:  2010-02-24       Impact factor: 4.256

3.  Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis?

Authors:  Pinaki Dutta; Anil Bhansali; Kim Vaiphei; Usha Dutta; P Ravi Kumar; Shariq Masoodi; Kanchan Kumar Mukherjee; Alka Varma; R Kochhar
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

Review 4.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

5.  Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9.

Authors:  Nicole M Ramocki; Heather R Wilkins; Scott T Magness; James G Simmons; Brooks P Scull; Ginny H Lee; Kirk K McNaughton; P Kay Lund
Journal:  Endocrinology       Date:  2007-10-04       Impact factor: 4.736

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.